Suven Life Sciences Limited

Adi Reddy Dwarampudi

Venkateswarlu Jasti

Ramakrishna Nirogi

Anil Karbhari Shinde

Pradeep Jayarajan

Ishtiyaque Ahmad

Ramasastri Kambhampati

Vishwottam Nagaraj Kandikere

Rama Sastri Kambhampati

Nagaraj Vishwottam Kandikere

Santosh Vishwakarma

Rambabu Namala

Sangram Keshari Saraf

Mohmadsadik Abdulhamid Mulla

Narasimhareddy Gangadasari

Laxman Kota

Murlimohan Gampa

Padmavathi Kodru

Taraka Naga Vinaykumar Tiriveedhi

Nageshwara Rao Muddana

Ramanatha Shrikantha Saralaya

Dhanalakshmi Shanmuganathan

Amol Dinakar Deshpande

Anand Vijaykumar Daulatabad

Taraka Naga Tiriveedhi

The present invention relates to novel acrylamide compounds of formula (I): wherein A, X, R, and Y are as defined herein, and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine Hreceptors.

Acrylamide compounds as histamine H3 receptor ligands

The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them.  The present invention also relates to a process for the preparation of above compounds of formula (I), and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to Histamine Hreceptors.

Compounds as histamine H3 receptor ligands

The present invention relates to heterocyclyl compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to Histamine Hreceptors, for example cognitive disorders, sleep disorders, obesity and pain. 

[object Object]

The present invention relates to novel aminoalkoxy arylsulfonamide compounds of the formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. These compounds are useful in the treatment of various disorders that are related to 5-HTreceptor functions. Specifically, the compounds of this invention are also useful in the treatment of various CNS disorders, hematological disorders, eating disorders, diseases associated with pain, respiratory diseases, genito-urological disorders, cardiovascular diseases and cancer. 

Growing community of inventors

Hyderabad Telangana, India

Adi Reddy Dwarampudi